Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vaxcyte (PCVX) Depreciation & Amortization (CF) (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Depreciation & Amortization (CF) data on record, last reported at $2.9 million in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) changed 0.3% to $2.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $16.4 million, a 82.89% increase, with the full-year FY2025 number at $16.4 million, up 134.13% from a year prior.
  • Depreciation & Amortization (CF) reached $2.9 million in Q1 2026 per PCVX's latest filing, down from $7.5 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for PCVX hit a ceiling of $7.5 million in Q4 2025 and a floor of $582000.0 in Q1 2022.
  • A 5-year average of $1.9 million and a median of $999000.0 in 2024 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): dropped 7.4% in 2023, then soared 222.52% in 2024.
  • Tracing PCVX's Depreciation & Amortization (CF) over 5 years: stood at $959000.0 in 2022, then fell by 7.4% to $888000.0 in 2023, then skyrocketed by 222.52% to $2.9 million in 2024, then soared by 161.77% to $7.5 million in 2025, then plummeted by 60.69% to $2.9 million in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for PCVX at $2.9 million in Q1 2026, $7.5 million in Q4 2025, and $3.1 million in Q3 2025.